AmerisourceBergen - ABC Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $180.08
  • Forecasted Upside: 14.99%
  • Number of Analysts: 13
  • Breakdown:
  • 0 Sell Ratings
  • 2 Hold Ratings
  • 11 Buy Ratings
  • 0 Strong Buy Ratings
$156.61
▲ +2.12 (1.37%)

This chart shows the closing price for ABC by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New AmerisourceBergen Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ABC and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ABC

Analyst Price Target is $180.08
▲ +14.99% Upside Potential
This price target is based on 13 analysts offering 12 month price targets for AmerisourceBergen in the last 3 months. The average price target is $180.08, with a high forecast of $201.00 and a low forecast of $169.00. The average price target represents a 14.99% upside from the last price of $156.61.

This chart shows the closing price for ABC for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 13 polled investment analysts is to buy stock in AmerisourceBergen. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 8 buy ratings
  • 2 hold ratings
  • 0 sell ratings
8/16/2021
  • 0 strong buy ratings
  • 8 buy ratings
  • 2 hold ratings
  • 0 sell ratings
11/14/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 3 hold ratings
  • 0 sell ratings
2/12/2022
  • 0 strong buy ratings
  • 4 buy ratings
  • 3 hold ratings
  • 0 sell ratings
5/13/2022
  • 0 strong buy ratings
  • 6 buy ratings
  • 3 hold ratings
  • 0 sell ratings
8/11/2022
  • 0 strong buy ratings
  • 9 buy ratings
  • 3 hold ratings
  • 0 sell ratings
11/9/2022
  • 0 strong buy ratings
  • 9 buy ratings
  • 2 hold ratings
  • 0 sell ratings
1/8/2023
  • 0 strong buy ratings
  • 11 buy ratings
  • 2 hold ratings
  • 0 sell ratings
2/7/2023

Latest Recommendations

  • 0 strong buy ratings
  • 11 buy ratings
  • 2 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/2/2023Robert W. BairdBoost TargetOutperform$199.00 ➝ $201.00Low
2/2/2023MizuhoBoost TargetNeutral$162.00 ➝ $170.00Low
1/31/2023UBS GroupBoost TargetBuy$184.00 ➝ $190.00Low
1/31/2023Evercore ISIReiterated RatingOutperform$185.00Low
1/12/2023ArgusBoost TargetBuy$170.00 ➝ $190.00Low
1/11/2023Robert W. BairdBoost TargetOutperform$195.00 ➝ $199.00Low
11/22/2022Credit Suisse GroupBoost TargetOutperform$175.00 ➝ $182.00Low
11/4/2022Robert W. BairdBoost Target$188.00 ➝ $195.00Low
10/18/2022CowenLower TargetOutperform$170.00 ➝ $169.00Low
10/18/2022CowenLower TargetOutperform$170.00 ➝ $169.00Low
10/11/2022Bank Of America (Bofa)UpgradeBuyLow
10/11/2022Bank of AmericaUpgradeNeutral ➝ Buy$160.00 ➝ $169.00N/A
8/22/2022Morgan StanleyBoost TargetEqual Weight$175.00 ➝ $176.00Low
8/4/2022Credit Suisse GroupLower TargetOutperform$180.00 ➝ $175.00Low
7/20/2022ArgusBoost TargetBuy$160.00 ➝ $170.00Low
6/13/2022UBS GroupBoost TargetBuy$144.00 ➝ $174.00High
6/9/2022CowenLower TargetOutperform$171.00 ➝ $170.00Medium
6/9/2022CowenLower Target$171.00 ➝ $170.00Medium
6/7/2022Deutsche Bank AktiengesellschaftUpgradeHold ➝ Buy$167.00 ➝ $178.00Low
6/3/2022Evercore ISILower Target$165.00Low
5/27/2022Morgan StanleyLower TargetEqual Weight$178.00 ➝ $175.00Medium
5/26/2022BarclaysUpgradeEqual Weight ➝ Overweight$175.00 ➝ $182.00Low
5/25/2022Deutsche Bank AktiengesellschaftLower Target$168.00 ➝ $167.00Low
5/5/2022Robert W. BairdBoost Target$179.00 ➝ $187.00Low
5/5/2022Deutsche Bank AktiengesellschaftBoost Target$153.00 ➝ $168.00Low
5/5/2022MizuhoBoost Target$139.00 ➝ $162.00Low
4/12/2022Morgan StanleyDowngradeOverweight ➝ Equal Weight$142.00 ➝ $178.00Low
3/14/2022ArgusBoost Target$140.00 ➝ $160.00Medium
2/3/2022Robert W. BairdBoost Target$175.00 ➝ $179.00Medium
2/3/2022MizuhoBoost TargetNeutral$130.00 ➝ $139.00Low
1/11/2022BarclaysBoost TargetEqual Weight$135.00 ➝ $152.00High
1/6/2022ScotiabankDowngradeOutperform ➝ Sector PerformHigh
12/17/2021Morgan StanleyBoost TargetOverweight$141.00 ➝ $142.00Medium
11/12/2021Deutsche Bank AktiengesellschaftBoost TargetHold$136.00 ➝ $153.00High
11/8/2021Credit Suisse GroupBoost TargetOutperform$144.00 ➝ $145.00Medium
11/5/2021BarclaysBoost TargetEqual Weight$130.00 ➝ $135.00Low
8/31/2021Morgan StanleyBoost TargetOverweight$138.00 ➝ $141.00Medium
8/5/2021Credit Suisse GroupBoost TargetOutperform$132.00 ➝ $144.00High
8/5/2021Robert W. BairdBoost TargetOutperform$156.00 ➝ $162.00High
6/20/2021Robert W. BairdReiterated RatingBuyMedium
5/6/2021BarclaysBoost TargetEqual Weight$122.00 ➝ $130.00Low
2/9/2021MizuhoBoost TargetNeutral$104.00 ➝ $114.00Low
2/8/2021Morgan StanleyBoost TargetOverweight$130.00 ➝ $138.00Medium
2/8/2021CowenBoost TargetOutperform$145.00 ➝ $150.00Low
2/5/2021Credit Suisse GroupBoost TargetOutperform$123.00 ➝ $127.00Low
2/4/2021Evercore ISIUpgradeIn-Line ➝ OutperformLow
2/1/2021CowenBoost TargetOutperform$129.00 ➝ $145.00Low
1/21/2021ArgusBoost TargetBuy$120.00 ➝ $140.00Medium
1/7/2021Deutsche Bank AktiengesellschaftBoost TargetHold$111.00 ➝ $115.00N/A
1/6/2021Bank of AmericaUpgradeUnderperform ➝ NeutralN/A
11/13/2020MizuhoBoost TargetNeutral$100.00 ➝ $104.00Medium
11/9/2020Credit Suisse GroupBoost TargetOutperform$118.00 ➝ $123.00Low
11/9/2020Morgan StanleyBoost TargetOverweight$121.00 ➝ $130.00Low
11/6/2020Deutsche Bank AktiengesellschaftBoost TargetHold$104.00 ➝ $111.00Low
8/10/2020UBS GroupBoost TargetBuy$99.00 ➝ $112.00Low
8/10/2020Credit Suisse GroupBoost TargetOutperform$111.00 ➝ $118.00Low
8/6/2020Morgan StanleyBoost TargetOverweight$112.00 ➝ $121.00High
7/21/2020Bank of AmericaBoost TargetUnderperform$85.00 ➝ $88.00Medium
6/15/2020Morgan StanleyUpgradeEqual Weight ➝ Overweight$94.00 ➝ $112.00Medium
5/15/2020UBS GroupLower TargetBuy$108.00 ➝ $99.00High
5/11/2020Deutsche Bank AktiengesellschaftBoost TargetHold$93.00 ➝ $98.00Medium
5/8/2020Morgan StanleyBoost TargetEqual Weight$84.00 ➝ $94.00High
4/22/2020Credit Suisse GroupInitiated CoverageBuy$105.00Low
4/1/2020JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$93.00 ➝ $106.00Medium
3/27/2020Morgan StanleyLower TargetEqual Weight$98.00 ➝ $84.00Medium
2/7/2020Robert W. BairdUpgradeNeutral ➝ Outperform$112.00Medium
2/2/2020Credit Suisse GroupReiterated RatingBuy$98.00Low
1/31/2020Robert W. BairdBoost TargetNeutral$93.00 ➝ $94.00High
1/31/2020Deutsche Bank AktiengesellschaftBoost TargetHold$79.00 ➝ $93.00High
1/19/2020BarclaysReiterated RatingHold$100.00Low
11/18/2019ArgusReiterated RatingBuy$110.00Low
9/12/2019Deutsche Bank AktiengesellschaftInitiated CoverageHold$91.00High
9/6/2019Morgan StanleyLower TargetEqual Weight$91.00 ➝ $83.00N/A
6/3/2019ArgusLower TargetBuy$115.00 ➝ $100.00Medium
4/11/2019GuggenheimInitiated CoverageBuyLow
4/10/2019Bank of AmericaDowngradeBuy ➝ Underperform$95.00 ➝ $76.00High
4/2/2019Wolfe ResearchInitiated CoverageMarket PerformHigh
1/17/2019UBS GroupInitiated CoverageBuy ➝ Buy$89.00Medium
1/6/2019BarclaysReiterated RatingHold$84.00Low
12/3/2018Morgan StanleyBoost TargetEqual Weight ➝ Equal Weight$88.00 ➝ $91.00Low
11/30/2018Royal Bank of CanadaLower TargetSector Perform ➝ Hold$90.00 ➝ $87.00Low
11/7/2018Royal Bank of CanadaSet TargetHold$90.00Low
9/19/2018MizuhoReiterated RatingNeutralMedium
8/12/2018MizuhoReiterated RatingHold$90.00Low
8/3/2018Robert W. BairdReiterated RatingHold$89.00Medium
7/20/2018Robert W. BairdDowngradeOutperform ➝ NeutralLow
7/20/2018Robert W. BairdReiterated RatingOutperform ➝ Neutral$94.00Low
7/3/2018Morgan StanleyLower TargetEqual Weight ➝ Equal Weight$97.00 ➝ $88.00Low
4/2/2018Royal Bank of CanadaSet TargetHold$101.00Medium
3/27/2018BarclaysLower TargetEqual Weight ➝ Equal Weight$104.00 ➝ $95.00Low
3/8/2018BarclaysInitiated CoverageEqual Weight ➝ Equal Weight$104.00Low
3/5/2018ArgusBoost TargetBuy$93.96 ➝ $115.00Low
2/27/2018CowenReiterated RatingBuy$108.00Low
2/27/2018Bank of AmericaInitiated CoverageBuy ➝ Buy$111.00High
2/8/2018Needham & Company LLCLower TargetBuy ➝ Buy$117.00 ➝ $113.00Medium
2/7/2018Jefferies Financial GroupSet TargetHold$95.00Medium
2/7/2018Credit Suisse GroupReiterated RatingOutperform ➝ Outperform$105.00 ➝ $112.00Medium
2/7/2018Royal Bank of CanadaReiterated RatingHold$102.00Medium
(Data available from 2/7/2018 forward)

News Sentiment Rating

0.77 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 2 very positive mentions
  • 16 positive mentions
  • 4 negative mentions
  • 0 very negative mentions
7/12/2022
  • 9 very positive mentions
  • 37 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
8/11/2022
  • 4 very positive mentions
  • 27 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
9/10/2022
  • 3 very positive mentions
  • 25 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
10/10/2022
  • 10 very positive mentions
  • 21 positive mentions
  • 3 negative mentions
  • 2 very negative mentions
11/9/2022
  • 7 very positive mentions
  • 21 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
12/9/2022
  • 4 very positive mentions
  • 5 positive mentions
  • 2 negative mentions
  • 6 very negative mentions
1/8/2023
  • 18 very positive mentions
  • 23 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
2/7/2023

Current Sentiment

  • 18 very positive mentions
  • 23 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
AmerisourceBergen logo
AmerisourceBergen Corp. engages in the provision of pharmaceutical products and business solutions that improve access to care. It operates through the Pharmaceutical Distribution Services and Other segments. The Pharmaceutical Distribution Services segment distributes an offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, and long-term care and alternate site pharmacies. The Other segment focuses on global commercialization services and animal health, and includes AmerisourceBergen Consulting Services ABCS, World Courier, and MWI. The company was founded by in Emil P. Martini in 1947 and is headquartered in Conshohocken, PA.
Read More

Today's Range

Now: $156.61
Low: $153.01
High: $156.89

50 Day Range

MA: $166.01
Low: $156.73
High: $173.99

52 Week Range

Now: $156.61
Low: $134.70
High: $174.63

Volume

549,506 shs

Average Volume

1,442,324 shs

Market Capitalization

$32.21 billion

P/E Ratio

19.01

Dividend Yield

1.24%

Beta

0.53

Frequently Asked Questions

What sell-side analysts currently cover shares of AmerisourceBergen?

The following equities research analysts have issued reports on AmerisourceBergen in the last year: Argus, Bank Of America (Bofa), Bank of America Co., Barclays PLC, Cowen Inc, Cowen Inc., Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, Evercore ISI, Mizuho, Morgan Stanley, Robert W. Baird, StockNews.com, TheStreet, and UBS Group AG.
View the latest analyst ratings for ABC.

What is the current price target for AmerisourceBergen?

12 Wall Street analysts have set twelve-month price targets for AmerisourceBergen in the last year. Their average twelve-month price target is $180.08, suggesting a possible upside of 16.6%. Robert W. Baird has the highest price target set, predicting ABC will reach $201.00 in the next twelve months. Cowen Inc. has the lowest price target set, forecasting a price of $169.00 for AmerisourceBergen in the next year.
View the latest price targets for ABC.

What is the current consensus analyst rating for AmerisourceBergen?

AmerisourceBergen currently has 2 hold ratings and 11 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe ABC will outperform the market and that investors should add to their positions of AmerisourceBergen.
View the latest ratings for ABC.

What other companies compete with AmerisourceBergen?

Other companies that are similar to AmerisourceBergen include Cardinal Health, McKesson, ResMed, Illumina and BioNTech. Learn More about companies similar to AmerisourceBergen.

How do I contact AmerisourceBergen's investor relations team?

AmerisourceBergen's physical mailing address is 1300 MORRIS DRIVE, CHESTERBROOK PA, 19087. The company's listed phone number is (610) 727-7000 and its investor relations email address is [email protected] The official website for AmerisourceBergen is www.amerisourcebergen.com. Learn More about contacing AmerisourceBergen investor relations.